Cost-utility analysis of adding abiraterone acetate plus prednisone/prednisolone to long-term hormone therapy in newly diagnosed advanced prostate cancer in England: Lifetime decision model based on STAMPEDE trial data
- Publication date
- 1 January 2022
- Publisher
- 'Public Library of Science (PLoS)'